US Market Report for Neurovascular Stents 2017 - MedCore

US Market Report for Neurovascular Stents 2017 - MedCore

High single digit market growth will be seen throughout the forecast period for neurovascular stents as next generation devices continue to enter the U.S. market. Traditional coil assisted stenting will continue to grow in unit sales while flow diversion stenting, a new and promising endovascular treatment, will experience rapid growth as well. Sales of these devices in the U.S. only began in 2011 following the approval of the Pipeline™ device from Medtronic. Flow diversion stents have the potential to cannibalize a portion of traditional stent sales but they will both continue to experience growth. These increases in unit sales will also be driven by innovation in these devices making them smaller and able to place in more distal locations. The high market value is in part attributable to the fact that flow diversion stents command an ASP of nearly twice that of a traditional stent. Both types of stents are expected to experience marginal increases in pricing due to innovation, which will also drive market growth.

There are two main types of neurovascular stents currently on the market, the traditional stent and the flow diverter stent. They are both used as treatments for cerebral aneurysms. Traditional neurovascular stents are small, flexible, tube-like devices used for stabilizing detachable coils within an aneurysm. They serve to block off the aneurysm and to prevent coils from slipping back into the main blood vessel. These stents are also used to treat intracranial stenosis by opening blocked arteries. These stents are delivered in reduced tube structures for easier navigation and delivery through the narrow intracranial vessels. As brain arteries are more fragile than carotid arteries, a self-expanding stent that gently opens to the desired vessel diameter is generally used. Self-expandable stents carry a lower risk of dissection or vessel rupture when compared to the balloon-expandable stents.


EXECUTIVE SUMMARY
U.S. NEUROMODULATION, NEUROVASCULAR, NEUROSURGICAL AND MONITORING DEVICE MARKET OVERVIEW
COMPETITIVE ANALYSIS
MARKET TRENDS
MARKET DEVELOPMENTS
PROCEDURE NUMBERS
PROCEDURE CODES INVESTIGATED
MARKETS INCLUDED
KEY REPORT UPDATES
VERSION HISTORY
RESEARCH METHODOLOGY
1.1 RESEARCH SCOPE
1.2 IDATA’S 9-STEP METHODOLOGY
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring
DISEASE OVERVIEW
2.1 BASIC ANATOMY
2.2 DISEASE PATHOLOGY AND DISORDERS
2.2.1 Introduction
2.2.2 General Diagnostics and Neurosurgery
2.2.3 Tumor and Brain Cancer
2.2.4 Brain Arteriovenous Malformations
2.2.5 Ischemic Stroke
2.2.6 Brain Aneurysm
2.2.7 Disorders Related to Cerebrospinal Fluids and Intracranial Pressure
2.2.7.1 Hydrocephalus and Intracranial Pressure Disorder
2.2.7.2 Cerebral Edema
2.2.8 Indication for Neuromodulation
2.2.9 Traumatic brain injury
PRODUCT ASSESSMENT
3.1 PRODUCT PORTFOLIOS
3.1.1 Neurovascular Stent
3.1.1.1 Introduction
3.1.1.2 Product Matrix for Neurovascular Stent Market: Core Companies
3.2 REGULATORY ISSUES AND RECALLS
3.2.1 Neurovascular Stent
3.3 CLINICAL TRIALS
3.3.1 Neurovascular Stent
NEUROVASCULAR STENT MARKET
4.1 INTRODUCTION
4.2 MARKET OVERVIEW
4.3 MARKET ANALYSIS AND FORECAST
4.3.1 Total Neurovascular Stent Market
4.3.2 Traditional Neurovascular Stent Market
4.3.3 Flow Diversion Stent Market
4.4 DRIVERS AND LIMITERS
4.4.1 Market Drivers
4.4.2 Market Limiters
4.5 COMPETITIVE MARKET SHARE ANALYSIS
ABBREVIATIONS
APPENDIX: COMPANY PRESS RELEASES
List of Charts
Chart 1 1: Neurological Device Market by Segment, U.S., 2013 – 2023
Chart 1 2: Neurological Device Market Overview, U.S., 2016 & 2023
Chart 4 1: Neurovascular Stent Market, U.S., 2013 – 2023
Chart 4 2: Neurovascular Stent Market Breakdown, U.S., 2016
Chart 4 3: Neurovascular Stent Market Breakdown, U.S., 2023
Chart 4 4: Total Neurovascular Stent Market, U.S., 2013 – 2023
Chart 4 5: Traditional Neurovascular Stent Market, U.S., 2013 – 2023
Chart 4 6: Flow Diversion Stent Market, U.S., 2013 – 2023
Chart 4 7: Leading Competitors, Neurovascular Stent Market, U.S., 2016
List of Figures
Figure 1 1: Neurological Device Market Share Ranking by Segment, U.S., 2016 (1 of 3)
Figure 1 2: Neurological Device Market Share Ranking by Segment, U.S., 2016 (2 of 3)
Figure 1 3: Neurological Device Market Share Ranking by Segment, U.S., 2016 (3 of 3)
Figure 1 4: Companies Researched in this Report, U.S., 2016
Figure 1 5: Factors Impacting the Neurological Device Market by Segment, U.S. (1 of 3)
Figure 1 6: Factors Impacting the Neurological Device Market by Segment, U.S. (2 of 3)
Figure 1 7: Factors Impacting the Neurological Device Market by Segment, U.S. (3 of 3)
Figure 1 8: Recent Events in the Neurological Device Market, U.S., 2014 – 2016
Figure 1 9: Neurological Device Markets Covered, U.S., 2016
Figure 1 10: Procedural Codes Investigated, U.S., 2016 (1 of 2)
Figure 1 11: Procedural Codes Investigated, U.S., 2016 (2 of 2)
Figure 1 12: Neurological Device Markets Covered, U.S., 2016 (1 of 2)
Figure 1 13: Neurological Device Markets Covered, U.S., 2016 (2 of 2)
Figure 1 14: Key Report Updates
Figure 1 15: Version History
Figure 2 1: Neurology Disease Overview
Figure 2 2: Brain/Other Nervous System Cancer Statistics by Type and Gender, U.S., 2016
Figure 3 1: Class 2 Device Recall: Pipeline and Pipeline Flex
Figure 3 2: Class 2 Device Recall: Stryker brand Neuroform 3 Microdelivery Stent System
Figure 3 3: Class 2 Device Recall: Wingspan Stent System
Figure 3 4: Neurovascular Stent: Safety and Effectiveness of an Intracranial Aneurysm Embolization System
Figure 3 5: Neurovascular Stent: Study of the Reverse Medical Barrel™ Vascular Reconstruction Device (VRD)
Figure 3 6: Neurovascular Stent: Flow Diverter Stent for Endovascular Treatment of Unruptured Saccular Wide-necked Intracranial Aneurysms (EVIDENCE)
Figure 3 7: Neurovascular Stent: Complete Occlusion of Coilable Aneurysms (COCOA)
Figure 3 8: Neurovasculr Stents: VISSIT Intracranial Stent Study for Ischemic Therapy (VISSIT)
Figure 3 9: Neurovasculr Stents: The Registry to Study Safety and Performance of the CORDIS Vascular Reconstruction Device and Delivery System (SUNRISE)
Figure 3 10: Neurovasculr Stents: Enterprise Stent Aneurysm Treatment (ESAT) Study - France (ESAT)
Figure 4 1: Neurovascular Stent Market, U.S., 2013 – 2023 (US$M)
Figure 4 2: Total Neurovascular Stent Market, U.S., 2013 – 2023
Figure 4 3: Traditional Neurovascular Stent Market, U.S., 2013 – 2023
Figure 4 4: Flow Diversion Stent Market, U.S., 2013 – 2023
Figure 4 5: Drivers and Limiters, Neurovascular Stent Market, U.S., 2016
Figure 4 6: Leading Competitors, Neurovascular Stent Market, U.S., 2016
Figure 6 1: Press Release Summary

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook